ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 81 filers reported holding ESSA PHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $76,410 | -90.3% | 28,300 | -89.3% | 0.00% | -90.9% |
| Q1 2023 | $785,776 | +17.9% | 264,571 | 0.0% | 0.01% | +10.0% |
| Q4 2022 | $666,719 | -93.3% | 264,571 | -24.1% | 0.01% | -92.4% |
| Q2 2021 | $9,957,000 | -37.8% | 348,524 | -36.8% | 0.13% | -44.1% |
| Q1 2021 | $16,010,000 | +28.0% | 551,122 | -47.4% | 0.24% | +16.8% |
| Q4 2020 | $12,509,000 | +377.1% | 1,048,524 | +175.9% | 0.20% | +274.1% |
| Q3 2020 | $2,622,000 | – | 380,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,145,117 | $12,310,997 | 1.28% |
| BVF INC/IL | 8,748,629 | $25,983,428 | 0.95% |
| Ally Bridge Group (NY) LLC | 236,583 | $702,652 | 0.92% |
| PFM Health Sciences, LP | 4,161,461 | $12,359,539 | 0.55% |
| Bellevue Group AG | 7,898,583 | $23,458,792 | 0.34% |
| Rhenman & Partners Asset Management AB | 356,500 | $1,051,675 | 0.12% |
| Orbimed Advisors | 1,198,337 | $3,559,061 | 0.07% |
| Privium Fund Management (UK) Ltd | 20,032 | $61,498 | 0.05% |
| Rock Springs Capital Management LP | 524,944 | $1,559,084 | 0.04% |
| Hunting Hill Global Capital, LLC | 10,000 | $29,700 | 0.02% |